NYSE · MTD
Mettler-Toledo International Inc.
Healthcare · Medical - Diagnostics & Research
$1,678.19▲ 0.20% ($3.38)at close
As of 4:00 PM ET
Valuation
Cash-flow DCF
Verdict: fairly priced. Price above Base.
The price needs 24.3% free cash flow growth a year for 5 years. Our scenarios assume −1.6–23.9%.
That's 2.7× its past 10-year pace.
Value per share
Base case
$865.03
Price used $1,678.19 is 1.9× this
USD · TTM ending Jun 30, 2026 · Price Nov 2, 9:00 PM UTC
Free cash flow each value needs
Free cash flow today $892M. The price needs $3.4B by 2036. Base case: $1.7B. At its recent pace: $2.1B. Bear to Bull: $977M to $4.8B.
Free cash flow today $892M. The price needs $3.4B by 2036. Base case: $1.7B. At its recent pace: $2.1B. Bear to Bull: $977M to $4.8B.
Free cash flow in 2036
today $892M
+$1.6Bmore than the Base case · 1.9×
Value per share · Base case
$865.03
Price $1,678.19
1.9× this
- Stage 1 growth, yrs 1–5
- 8.9%
- Stage 2 growth, yrs 6–10
- 4.9%
- Discount rate
- 9.4%
USD · TTM ending Jun 30, 2026 · Price Nov 2, 9:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 19.28% over the last year. Revenue grew 6.91% over the trailing twelve months. Operating margin moved from 28.38% to 28.41%. Free cash flow grew 1.9% over the trailing twelve months.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/FCF range (64th percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at 28.41% — continued expansion would be needed to justify the premium. Revenue growth of 6.91% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Return analysis
Company profile
Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services.
Market multiples
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
8
Buy
11
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Nov 5, 2026
Q3 FY26 · EPS est $12.13 · Revenue est $1.1B
Same quarter, year over year
FY26 YTD +11.4%Each cell vs the same quarter a year earlier (the cell below) · Q1–Q2 combined $20.37 vs $18.28 · all 2 quarters up
Q1
Q2
Q3
Q4
FY total
FY26
—
—
FY25
FY24
FY23
—
—
—
Fiscal year totals
- FY25
- $42.79
- +4.0%
- FY24
- $41.16
- —
Q2 FY26
Reported Jul 30, 2026 · Latest
HoverTap a cell to inspect
Actual
$11.46
Estimate
$10.85
Year over year
+13.6%
Vs prior quarter
+28.6%
Institutional Sentiment
Mettler-Toledo International Inc. · MTD
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.